Detalhe da pesquisa
1.
The management of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 136-150, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38037886
2.
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 127-135, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37932932
3.
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.
Nat Commun
; 14(1): 7725, 2023 Nov 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38001082
4.
Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
NEJM Evid
; 2(6): EVIDoa2200339, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38320129
5.
Guideline for the investigation and management of eosinophilia.
Br J Haematol
; 176(4): 553-572, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28112388
6.
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study.
Ther Adv Hematol
; 13: 20406207221084487, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35371428
7.
Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology guideline
Br. j. haematol
; 204(1): 127-134, 20240101.
Artigo
Inglês
| BIGG | ID: biblio-1537641
8.
The management of myelofibrosis: a British Society for Haematology guideline
Br. j. haematol
; 204(1): 136-150, 20240101.
Artigo
Inglês
| BIGG | ID: biblio-1537635
9.
Evidence that a BCR-ABL fusion peptide does not induce lymphocyte proliferation or cytokine production in vitro.
Leuk Res
; 31(12): 1675-81, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17324459
10.
Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects.
Haematologica
; 90(10): 1315-23, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16219567
11.
CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.
Leuk Lymphoma
; 44(9): 1509-13, 2003 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-14565652
12.
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia.
Leuk Res
; 37(7): 752-8, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23618689
13.
A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials.
Leukemia
; 22(10): 1963-6, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18754023
14.
BCR-ABL-specific T cells can be detected in healthy donors and in chronic myeloid leukemia patients following allogeneic stem cell transplantation.
Blood
; 103(8): 3245, 2004 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15070713